Enloplatin - CISMeF

Preferred Label : Enloplatin;

NCIt synonyms : Platinum, (1,1-Cyclobutanedicarboxylato(2-))(Tetrahydro-4h-Pyran-4,4-Dimethanamine-N,N')-, (Sp-4-2)-; Cis-(1,1-Cyclobutanedicarboxylato)(Tetrahydro-4H-Pyran-4,4-Bis(Methylamine))Platinum;

NCIt definition : A platinum-based alkylating agent with antineoplastic activity. Although its pharmacokinetic properties are similar to that of carboplatin, enloplatin appears to be non-cross resistant with other platinum-based agents, such as cisplatin and carboplatin.;

UNII : C7HT2IO79H;

CAS number : 111523-41-2;

Molecule name : CL 287,110; CL-287110;

Chemical formula : C7H16N2O.C6H6O4.Pt;

Details

Origin ID

C95323;

UMLS CUI

C0165431;

Currated CISMeF NLP mapping
- enloplatin [MeSH concept]
- enloplatin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- enloplatin [MeSH concept]
- enloplatin [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients